Literature DB >> 26188567

Diversity and antimicrobial susceptibility profiling of staphylococci isolated from bovine mastitis cases and close human contacts.

T Schmidt1, M M Kock2, M M Ehlers2.   

Abstract

The objectives of this study were to examine the diversity of Staphylococcus spp. recovered from bovine intramammary infections and humans working in close contact with the animals and to evaluate the susceptibility of the staphylococcal isolates to different antimicrobials. A total of 3,387 milk samples and 79 human nasal swabs were collected from 13 sampling sites in the KwaZulu-Natal province of South Africa. In total, 146 Staph. aureus isolates and 102 coagulase-negative staphylococci (CNS) were recovered from clinical and subclinical milk samples. Staphylococcusaureus was isolated from 12 (15.2%) of the human nasal swabs and 95 representative CNS were recovered for further characterization. The CNS were identified using multiplex-PCR assays, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), and tuf gene sequencing. Seven Staphylococcus spp. were identified among the CNS of bovine origin, with Staph.chromogenes (78.4%) predominating. The predominant CNS species recovered from the human nasal swabs was Staph.epidermidis (80%) followed by Staph.chromogenes (6.3%). The antimicrobial susceptibility of all staphylococcal isolates was evaluated using disk diffusion and was supplemented by screening for specific antimicrobial resistance genes. Ninety-eight (67.1%) Staph.aureus isolates of bovine origin were pansusceptible; 39 (26.7%) isolates were resistant to a single class, and 7 (4.8%) isolates were resistant to 2 classes of antimicrobials. Two Staph. aureus (1.4%) isolates were multidrug-resistant. Resistance to penicillin was common, with 28.8% of the bovine and 75% of the human Staph. aureus isolates exhibiting resistance. A similar observation was made with the CNS, where 37.3% of the bovine and 89.5% of the human isolates were resistant to penicillin. Multidrug-resistance was common among the human CNS, with 39% of the isolates exhibiting resistance to 3 or more classes of antimicrobials. The antimicrobial susceptibility results suggest that resistance among staphylococci causing bovine intramammary infections in South Africa is uncommon and not a significant cause for concern. In contrast, antimicrobial resistance was frequently observed in staphylococcal isolates of human origin, highlighting a possible reservoir of resistance genes. Continued monitoring of staphylococcal isolates is warranted to monitor changes in the susceptibility of isolates to different classes of antimicrobials.
Copyright © 2015 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Staphylococcus spp; antimicrobial resistance; bovine mastitis; close human contact

Mesh:

Substances:

Year:  2015        PMID: 26188567     DOI: 10.3168/jds.2015-9715

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  16 in total

1.  Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.

Authors:  N Misra; T F Wines; C L Knopp; R Hermann; L Bond; B Mitchell; M A McGuire; J K Tinker
Journal:  Vaccine       Date:  2018-05-05       Impact factor: 3.641

2.  Epidemiological investigation of subclinical bovine mastitis in Algeria and molecular characterization of biofilm-forming Staphylococcus aureus.

Authors:  Nawel Zaatout; Ammar Ayachi; Mouloud Kecha
Journal:  Trop Anim Health Prod       Date:  2019-07-23       Impact factor: 1.559

3.  Combined analysis of DNA methylome and transcriptome reveal novel candidate genes with susceptibility to bovine Staphylococcus aureus subclinical mastitis.

Authors:  Minyan Song; Yanghua He; Huangkai Zhou; Yi Zhang; Xizhi Li; Ying Yu
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

4.  Identification of Emerging Human Mastitis Pathogens by MALDI-TOF and Assessment of Their Antibiotic Resistance Patterns.

Authors:  María Marín; Rebeca Arroyo; Irene Espinosa-Martos; Leónides Fernández; Juan M Rodríguez
Journal:  Front Microbiol       Date:  2017-07-12       Impact factor: 5.640

5.  Prevalence and antimicrobial resistance profile of Staphylococcus in dairy farms, abattoir and humans in Addis Ababa, Ethiopia.

Authors:  Takele Beyene; Halefom Hayishe; Fikru Gizaw; Ashenafi Feyisa Beyi; Fufa Abunna; Bedaso Mammo; Dinka Ayana; Hika Waktole; Reta Duguma Abdi
Journal:  BMC Res Notes       Date:  2017-04-28

6.  Molecular Characterization of Staphylococcus aureus Isolated from Bovine Mastitis and Close Human Contacts in South African Dairy Herds: Genetic Diversity and Inter-Species Host Transmission.

Authors:  Tracy Schmidt; Marleen M Kock; Marthie M Ehlers
Journal:  Front Microbiol       Date:  2017-04-06       Impact factor: 5.640

Review 7.  Systematic review in South Africa reveals antibiotic resistance genes shared between clinical and environmental settings.

Authors:  Mutshiene Deogratias Ekwanzala; John Barr Dewar; Ilunga Kamika; Maggy Ndombo Benteke Momba
Journal:  Infect Drug Resist       Date:  2018-10-17       Impact factor: 4.003

8.  Identification and characterization of Staphylococcus devriesei isolates from bovine intramammary infections in KwaZulu-Natal, South Africa.

Authors:  Tracy Schmidt; Marleen M Kock; Marthie M Ehlers
Journal:  BMC Vet Res       Date:  2018-11-03       Impact factor: 2.741

9.  Antimicrobial consumption on Austrian dairy farms: an observational study of udder disease treatments based on veterinary medication records.

Authors:  Clair L Firth; Annemarie Käsbohrer; Corina Schleicher; Klemens Fuchs; Christa Egger-Danner; Martin Mayerhofer; Hermann Schobesberger; Josef Köfer; Walter Obritzhauser
Journal:  PeerJ       Date:  2017-11-16       Impact factor: 2.984

10.  Biofilm formation of methicillin-resistant coagulase negative staphylococci (MR-CoNS) isolated from community and hospital environments.

Authors:  Rathanin Seng; Thawatchai Kitti; Rapee Thummeepak; Phattaraporn Kongthai; Udomluk Leungtongkam; Surat Wannalerdsakun; Sutthirat Sitthisak
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.